IceCure Medical Investor Relations Material
Latest events
Q2 2025
IceCure Medical
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from IceCure Medical Ltd
Access all reports
IceCure Medical Ltd. is a commercial-stage medical device company that focuses on the development and marketing of cryoablation systems. Utilizing liquid nitrogen-based technology, the company offers minimally invasive treatments for both benign and malignant tumors, primarily targeting applications in women's health and interventional oncology. IceCure Medical's flagship product, the ProSense Cryoablation System, destroys tumors by freezing them, providing an alternative to traditional surgical tumor removal. IceCure Medical Ltd. is headquartered in Caesarea, Israel, and its shares are listed on the NASDAQ.
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
ICCM
Country
🇺🇸 United States